| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 56,942 | 54,067 | 46,270 | 21,453 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 54,067 | 46,270 | 21,453 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 39,303 | 36,293 | 40,023 | 38,728 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 12,591 | 17,774 | 6,247 | (17,275) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 17,638 | 17,774 | 6,247 | (17,275) | | Interest Expense | 1,683 | 1,684 | 1,680 | 1,680 | | Income Before Tax | 15,955 | 16,090 | 4,567 | (18,955) | | Income Tax Expense | 1,380 | 1,886 | 1,089 | 812 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 14,575 | 14,204 | 3,478 | (19,767) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,575 | 14,204 | 3,478 | (19,767) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,575 | $14,204 | $3,478 | ($19,767) |
|
0.09% Nasdaq 
0.16%
Income Statement
